List of Tables
Table 1. Global Implantable Neuromodulation Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Implantable Neuromodulation Device Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Implantable Neuromodulation Device Market Competitive Situation by Manufacturers in 2024
Table 4. Global Implantable Neuromodulation Device Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Implantable Neuromodulation Device Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Implantable Neuromodulation Device Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Implantable Neuromodulation Device Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Implantable Neuromodulation Device Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Implantable Neuromodulation Device, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Implantable Neuromodulation Device, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Implantable Neuromodulation Device, Product Type & Application
Table 12. Global Key Manufacturers of Implantable Neuromodulation Device, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Implantable Neuromodulation Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Neuromodulation Device as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Implantable Neuromodulation Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Implantable Neuromodulation Device Sales by Region (2020-2025) & (K Units)
Table 18. Global Implantable Neuromodulation Device Sales Market Share by Region (2020-2025)
Table 19. Global Implantable Neuromodulation Device Sales by Region (2026-2031) & (K Units)
Table 20. Global Implantable Neuromodulation Device Sales Market Share by Region (2026-2031)
Table 21. Global Implantable Neuromodulation Device Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Implantable Neuromodulation Device Revenue Market Share by Region (2020-2025)
Table 23. Global Implantable Neuromodulation Device Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Implantable Neuromodulation Device Revenue Market Share by Region (2026-2031)
Table 25. North America Implantable Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Implantable Neuromodulation Device Sales by Country (2020-2025) & (K Units)
Table 27. North America Implantable Neuromodulation Device Sales by Country (2026-2031) & (K Units)
Table 28. North America Implantable Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Implantable Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Implantable Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Implantable Neuromodulation Device Sales by Country (2020-2025) & (K Units)
Table 32. Europe Implantable Neuromodulation Device Sales by Country (2026-2031) & (K Units)
Table 33. Europe Implantable Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Implantable Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Implantable Neuromodulation Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Implantable Neuromodulation Device Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Implantable Neuromodulation Device Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Implantable Neuromodulation Device Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Implantable Neuromodulation Device Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Implantable Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Implantable Neuromodulation Device Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Implantable Neuromodulation Device Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Implantable Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Implantable Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Implantable Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Implantable Neuromodulation Device Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Implantable Neuromodulation Device Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Implantable Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Implantable Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Implantable Neuromodulation Device Sales (K Units) by Type (2020-2025)
Table 51. Global Implantable Neuromodulation Device Sales (K Units) by Type (2026-2031)
Table 52. Global Implantable Neuromodulation Device Sales Market Share by Type (2020-2025)
Table 53. Global Implantable Neuromodulation Device Sales Market Share by Type (2026-2031)
Table 54. Global Implantable Neuromodulation Device Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Implantable Neuromodulation Device Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Implantable Neuromodulation Device Revenue Market Share by Type (2020-2025)
Table 57. Global Implantable Neuromodulation Device Revenue Market Share by Type (2026-2031)
Table 58. Global Implantable Neuromodulation Device Price (US$/Unit) by Type (2020-2025)
Table 59. Global Implantable Neuromodulation Device Price (US$/Unit) by Type (2026-2031)
Table 60. Global Implantable Neuromodulation Device Sales (K Units) by Application (2020-2025)
Table 61. Global Implantable Neuromodulation Device Sales (K Units) by Application (2026-2031)
Table 62. Global Implantable Neuromodulation Device Sales Market Share by Application (2020-2025)
Table 63. Global Implantable Neuromodulation Device Sales Market Share by Application (2026-2031)
Table 64. Global Implantable Neuromodulation Device Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Implantable Neuromodulation Device Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Implantable Neuromodulation Device Revenue Market Share by Application (2020-2025)
Table 67. Global Implantable Neuromodulation Device Revenue Market Share by Application (2026-2031)
Table 68. Global Implantable Neuromodulation Device Price (US$/Unit) by Application (2020-2025)
Table 69. Global Implantable Neuromodulation Device Price (US$/Unit) by Application (2026-2031)
Table 70. Medtronic Company Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Implantable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Medtronic Implantable Neuromodulation Device Product
Table 74. Medtronic Recent Developments/Updates
Table 75. Abbott Company Information
Table 76. Abbott Description and Business Overview
Table 77. Abbott Implantable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Abbott Implantable Neuromodulation Device Product
Table 79. Abbott Recent Developments/Updates
Table 80. Boston Scientific Corporation Company Information
Table 81. Boston Scientific Corporation Description and Business Overview
Table 82. Boston Scientific Corporation Implantable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Boston Scientific Corporation Implantable Neuromodulation Device Product
Table 84. Boston Scientific Corporation Recent Developments/Updates
Table 85. St. Jude Medical Company Information
Table 86. St. Jude Medical Description and Business Overview
Table 87. St. Jude Medical Implantable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. St. Jude Medical Implantable Neuromodulation Device Product
Table 89. St. Jude Medical Recent Developments/Updates
Table 90. Synapse Biomedical Company Information
Table 91. Synapse Biomedical Description and Business Overview
Table 92. Synapse Biomedical Implantable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Synapse Biomedical Implantable Neuromodulation Device Product
Table 94. Synapse Biomedical Recent Developments/Updates
Table 95. Nevro Corporation Company Information
Table 96. Nevro Corporation Description and Business Overview
Table 97. Nevro Corporation Implantable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Nevro Corporation Implantable Neuromodulation Device Product
Table 99. Nevro Corporation Recent Developments/Updates
Table 100. Neuropace Company Information
Table 101. Neuropace Description and Business Overview
Table 102. Neuropace Implantable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Neuropace Implantable Neuromodulation Device Product
Table 104. Neuropace Recent Developments/Updates
Table 105. Cyberonics Company Information
Table 106. Cyberonics Description and Business Overview
Table 107. Cyberonics Implantable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Cyberonics Implantable Neuromodulation Device Product
Table 109. Cyberonics Recent Developments/Updates
Table 110. Autonomic Technologies Company Information
Table 111. Autonomic Technologies Description and Business Overview
Table 112. Autonomic Technologies Implantable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Autonomic Technologies Implantable Neuromodulation Device Product
Table 114. Autonomic Technologies Recent Developments/Updates
Table 115. Avery Biomedical Company Information
Table 116. Avery Biomedical Description and Business Overview
Table 117. Avery Biomedical Implantable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Avery Biomedical Implantable Neuromodulation Device Product
Table 119. Avery Biomedical Recent Developments/Updates
Table 120. Greatbatch Medical Company Information
Table 121. Greatbatch Medical Description and Business Overview
Table 122. Greatbatch Medical Implantable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Greatbatch Medical Implantable Neuromodulation Device Product
Table 124. Greatbatch Medical Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Implantable Neuromodulation Device Distributors List
Table 128. Implantable Neuromodulation Device Customers List
Table 129. Implantable Neuromodulation Device Market Trends
Table 130. Implantable Neuromodulation Device Market Drivers
Table 131. Implantable Neuromodulation Device Market Challenges
Table 132. Implantable Neuromodulation Device Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Implantable Neuromodulation Device
Figure 2. Global Implantable Neuromodulation Device Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Implantable Neuromodulation Device Market Share by Type: 2024 & 2031
Figure 4. Spinal Cord Stimulation Product Picture
Figure 5. Deep Brain Stimulation Product Picture
Figure 6. Gastric Stimulation Product Picture
Figure 7. Transcranial Magnetic Stimulation Product Picture
Figure 8. Transcutaneous Electrical Stimulation Product Picture
Figure 9. Other Product Picture
Figure 10. Global Implantable Neuromodulation Device Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Implantable Neuromodulation Device Market Share by Application: 2024 & 2031
Figure 12. Parkinson's Disease
Figure 13. Epilepsy
Figure 14. Pain
Figure 15. Other
Figure 16. Global Implantable Neuromodulation Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Implantable Neuromodulation Device Market Size (2020-2031) & (US$ Million)
Figure 18. Global Implantable Neuromodulation Device Sales (2020-2031) & (K Units)
Figure 19. Global Implantable Neuromodulation Device Average Price (US$/Unit) & (2020-2031)
Figure 20. Implantable Neuromodulation Device Report Years Considered
Figure 21. Implantable Neuromodulation Device Sales Share by Manufacturers in 2024
Figure 22. Global Implantable Neuromodulation Device Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Implantable Neuromodulation Device Players: Market Share by Revenue in Implantable Neuromodulation Device in 2024
Figure 24. Implantable Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Implantable Neuromodulation Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Implantable Neuromodulation Device Sales Market Share by Country (2020-2031)
Figure 27. North America Implantable Neuromodulation Device Revenue Market Share by Country (2020-2031)
Figure 28. United States Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Implantable Neuromodulation Device Sales Market Share by Country (2020-2031)
Figure 31. Europe Implantable Neuromodulation Device Revenue Market Share by Country (2020-2031)
Figure 32. Germany Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Implantable Neuromodulation Device Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Implantable Neuromodulation Device Revenue Market Share by Region (2020-2031)
Figure 39. China Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. China Taiwan Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Indonesia Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Thailand Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Malaysia Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Implantable Neuromodulation Device Sales Market Share by Country (2020-2031)
Figure 49. Latin America Implantable Neuromodulation Device Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Implantable Neuromodulation Device Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Implantable Neuromodulation Device Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Implantable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Implantable Neuromodulation Device by Type (2020-2031)
Figure 59. Global Revenue Market Share of Implantable Neuromodulation Device by Type (2020-2031)
Figure 60. Global Implantable Neuromodulation Device Price (US$/Unit) by Type (2020-2031)
Figure 61. Global Sales Market Share of Implantable Neuromodulation Device by Application (2020-2031)
Figure 62. Global Revenue Market Share of Implantable Neuromodulation Device by Application (2020-2031)
Figure 63. Global Implantable Neuromodulation Device Price (US$/Unit) by Application (2020-2031)
Figure 64. Implantable Neuromodulation Device Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
